Frequency of TTG Positivity in Diarrhea Predominant IBS Patients at Peshawar, Pakistan
TTG Positivity in Diarrhea Predominant IBS Patients
DOI:
https://doi.org/10.54393/pjhs.v5i10.1529Keywords:
Celiac disease, chemiluminescence immunoassay, diarrhea, irritable bowel syndrome, tissue transglutaminase antibodiesAbstract
Irritable Bowel Syndrome is abdominal discomfort and alterations in bowel habits without an identifiable organic cause. Objective: To determine the frequency of tissue transglutaminase positivity in diarrhea-predominant IBS patients. Methods: This cross-sectional study was done from 1st January 2021 to 30th July 2021 in the Medicine department of Khyber Teaching Hospital, Peshawar, Pakistan. Patients of either gender aged between 18-60 years presenting in the medical outpatient department with diarrhea-predominant irritable bowel syndrome. Diarrhea-predominant irritable bowel syndrome was defined as a patient who fulfilled the Rome-IV criteria for irritable bowel syndrome with ≥2 of the features. Tissue transglutaminase antibodies were done for all patients and tissue transglutaminase positivity was defined as anti-tissue transglutaminase IgA or IgG antibody levels ≥10 AU/ml on laboratory tests performed by the chemi-luminescence immunoassay technique. Results: In a total of 96 patients, 59 (61.5%) were male. The mean age, weight, and duration of diarrhea were 37.64 ± 6.28 years, 81.48 ± 7.70 kg, and 11.67 ± 3.81 months, respectively. The tissue transglutaminase positivity was seen in 12 (12.5%) of patients. Duration of disease above 6 weeks was found to have a significant association with tissue transglutaminase positivity (p<0.001) as all tissue transglutaminase-positive patients had a duration of disease above 6 months. Conclusions: It was concluded that the frequency of tissue transglutaminase positivity was high in diarrhea-predominant irritable bowel syndrome patients. Screening for celiac disease in irritable bowel syndrome patients can be worth considering especially in cases with relatively longer duration of irritable bowel syndrome diarrhea predominant symptoms.
References
Altomare A, Di Rosa C, Imperia E, Emerenziani S, Cicala M, Guarino MP. Diarrhea Predominant-irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms. Nutrients. 2021 Apr; 13(5): 2-25. doi:10.3390/nu13051506.
Canavan C, West J, Card T. The Epidemiology of Irritable Bowel Syndrome. Clinical Epidemiology. 2014 Feb; 6: 71-80. doi: 10.2147/CLEP.S40245.
Hungin AP, Chang L, Locke GR, Dennis EH, Barghout V. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Alimentary pharmacology & therapeutics. 2005 Jun; 21(11): 1365-1375. doi:10.1111/j.1365-2036.2005.02463.x.
Tang HY, Jiang AJ, Wang XY, Wang H, Guan YY, Li F et al. Uncovering the Pathophysiology of Irritable Bowel Syndrome by Exploring the Gut-Brain Axis: A Narrative Review. Annals of Translational Medicine. 2021 Jul; 9(14): 1-13. doi: 10.21037/atm-21-2779.
Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2021 Jan 1;116(1):17-44. doi: 10.14309/ajg.0000000000001036. PMID: 33315591.
Butt N, Shahid B, Butt S, Channa MM, Reema S, Akbar A. Clinical Spectrum of Celiac Disease among Adult Population: Experience from Largest Tertiary Care Hospital in Karachi, Pakistan. Euroasian J Hepatogastroenterol. 2024 Jan-Jun;14(1):24-29. doi: 10.5005/jp-journals-10018-1420.
Medhat A, Abd El Salam N, Hassany SM, Hussein HI, Blum HE. Frequency of Celiac Disease in Egyptian Patients with Chronic Diarrhea: Endoscopic, Histopathologic and Immunologic Evaluation. J Physiol Pathophysiol. 2011 Feb; 2(1): 1-5.
Seidita A, Mansueto P, Compagnoni S, Castellucci D, Soresi M, Chiarello G, et al. Anemia in Celiac Disease: Prevalence, Associated Clinical and Laboratory Features, and Persistence after Gluten-Free Diet. J Pers Med. 2022 Sep 26;12(10):1582. doi: 10.3390/jpm12101582.
Mohammad BY, Al-Dohouky L, Mohammed AA. Prevalence of Anti-tissue Transglutaminase Antibodies in Patients with Irritable Bowel Syndrome in Duhok City. Journal of Coloproctology (Rio de Janeiro). 2019 Dec; 39(4): 346-350. doi: 10.1016/j.jcol.2019.08.001
Isa HM, Farid E, Makhlooq JJ, Mohamed AM, Al-Arayedh JG, Alahmed FA, Medani S. Celiac Disease in Children: Increasing Prevalence and Changing Clinical Presentations. Clinical and Experimental Pediatrics. 2021 Jun; 64(6): 301-309. doi: 10.3345/cep.2020.00304.
Sanders DS, Carter MJ, Hurlstone DP, Pearce A, Ward AM, McAlindon ME et al. Association of Adult Coeliac Disease with Irritable Bowel Syndrome: A Case-Control Study in Patients fulfilling ROME II Criteria referred to Secondary Care. The Lancet. 2001 Nov; 358(9292): 1504-1508. doi: 10.1016/S0140-6736(01)06581-3.
Sanders DS, Patel D, Stephenson TJ, Ward AM, McCloskey EV, Hadjivassiliou M et al. A Primary Care Cross-Sectional Study of Undiagnosed Adult Coeliac Disease. European Journal of Gastroenterology & Hepatology. 2003 Apr; 15(4): 407-413. doi: 10.1097/00042737-200304000-00012.
Jadallah KA, Khader YS. Celiac Disease in Patients with Presumed Irritable Bowel Syndrome: A Case-Finding Study. World Journal of Gastroenterology: WJG. 2009 Nov; 15(42): 5321-5325. doi: 10.3748/wjg.15.5321.
Hoseini-Asl MK and Amra B. Prevalence of Irritable Bowel Syndrome in Shahrekord, Iran. Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology. 2003 Nov; 22(6): 215-6.
Al-Abachi KT. Screening for Celiac Disease in Patients with Irritable Bowel Syndrome Fulfilling Rome III criteria. Journal of Coloproctology. 2022 Mar; 42(01): 020-024. doi: 10.1055/s-0041-1736645
Caio G, Volta U, Sapone A, Leffler DA, De Giorgio R, Catassi C et al. Celiac Disease: A Comprehensive Current Review. BMC Medicine. 2019 Dec; 17(142): 1-20. doi: 10.1186/s12916-019-1380-z.
Sharma N, Bhatia S, Chunduri V, Kaur S, Sharma S, Kapoor P et al. Pathogenesis of Celiac Disease and other Gluten Related Disorders in Wheat and Strategies for Mitigating them. Frontiers in Nutrition. 2020 Feb; 7(6): 1-26. doi: 10.3389/fnut.2020.00006.
Spiegel BM, DeRosa VP, Gralnek IM, Wang V, Dulai GS. Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis. Gastroenterology. 2004 Jun;126(7):1721-32. doi: 10.1053/j.gastro.2004.03.012.
Panezai MS, Ullah A, Ballur K, Gilstrap L, Khan J, Tareen B, Kakar M, Khan J, Rasheed A, Waheed A, Ghleilib I, White J, Cason FD. Frequency of Celiac Disease in Patients With Chronic Diarrhea. Cureus. 2021 Dec 17;13(12):e20495. doi: 10.7759/cureus.20495.
Lebwohl B, Sanders DS, Green PH. Coeliac disease. The Lancet. 2018 Jan; 391(10115): 70-81. doi: 10.1016/S0140-6736(17)31796-8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments